⌘K
Loading ticker…
As of 2026-08-24, Context Therapeutics Inc. Common Stock (CNTX) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 26. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.3%, relative volume 0.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CNTX appears in 1 ETF as of May 2026: AVSC at 0.01% weight, $154K notional.
Held by 3 ETFs · $9M across latest filings · largest weight 0.01% (AVSC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVSC | 0.01% | $154K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CNTX Jan avg: 29.36% median: 26.46% win: 50% σ: 47.45% n: 4 2022-04-12 → 2026-07-31 | CNTX Feb avg: -8.05% median: -8.30% win: 25% σ: 16.59% n: 4 2022-04-12 → 2026-07-31 | CNTX Mar avg: -5.13% median: -5.27% win: 50% σ: 27.69% n: 4 2022-04-12 → 2026-07-31 | CNTX Apr avg: 1.19% median: -2.58% win: 40% σ: 25.26% n: 5 2022-04-12 → 2026-07-31 | CNTX May avg: 27.76% median: 47.28% win: 80% σ: 36.64% n: 5 2022-04-12 → 2026-07-31 | CNTX Jun avg: 2.56% median: 1.26% win: 60% σ: 58.55% n: 5 2022-04-12 → 2026-07-31 | CNTX Jul avg: -2.95% median: 7.73% win: 60% σ: 18.09% n: 5 2022-04-12 → 2026-07-31 | CNTX Aug avg: 5.78% median: 7.21% win: 75% σ: 10.44% n: 4 2022-04-12 → 2026-07-31 (current) | CNTX Sep avg: 0.01% median: -2.50% win: 50% σ: 38.94% n: 4 2022-04-12 → 2026-07-31 | CNTX Oct avg: 1.86% median: 11.87% win: 75% σ: 21.13% n: 4 2022-04-12 → 2026-07-31 | CNTX Nov avg: -9.45% median: -8.53% win: 50% σ: 18.71% n: 4 2022-04-12 → 2026-07-31 | CNTX Dec avg: -4.88% median: 0.16% win: 50% σ: 43.62% n: 4 2022-04-12 → 2026-07-31 |